دورية أكاديمية
أعرض في EDS

Cervical cancer screening integrated in routine clinical care of women with HIV.

التفاصيل البيبلوغرافية
العنوان: Cervical cancer screening integrated in routine clinical care of women with HIV.
المؤلفون: Gram EJPN; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre., Moseholm E; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre.; Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen., Nørløv AB; Department of Gynecology and Obstetrics, Copenhagen University Hospital, Hvidovre., Wilken-Jensen C; Department of Gynecology and Obstetrics, Copenhagen University Hospital, Hvidovre., Thorsteinsson K; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre.; Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, Bispebjerg., Pedersen BT; Department of Pathology, Copenhagen University Hospital, Hvidovre., Jørgensen SM; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre., Bonde J; Department of Pathology, Copenhagen University Hospital, Hvidovre., Omland LH; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet., Lebech AM; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Weis N; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
المصدر: AIDS (London, England) [AIDS] 2024 Sep 01; Vol. 38 (11), pp. 1648-1657. Date of Electronic Publication: 2024 Jun 27.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE
أسماء مطبوعة: Publication: 1998- : London, England : Lippincott Williams & Wilkins
Original Publication: London : Gower Academic Journals, c1987-
مواضيع طبية MeSH: Uterine Cervical Neoplasms*/diagnosis , HIV Infections*/complications , Early Detection of Cancer* , Papillomavirus Infections*/complications, Humans ; Female ; Adult ; Denmark/epidemiology ; Middle Aged ; Cohort Studies ; Papillomaviridae/genetics ; Papillomaviridae/isolation & purification ; Incidence ; Genotype ; Prevalence ; Mass Screening
مستخلص: Objective: To evaluate if integrated cervical cancer screening (CCS) for women with HIV (WWH) in routine HIV care resulted in increased adherence to screening, and to describe the prevalence of human papillomavirus (HPV)-specific genotypes and the incidence of cellular abnormalities.
Design: Cohort study.
Methods: WWH who accepted the offer of combined CCS and HIV care (group 1), WWH who declined the offer (group 2), and WWH not offered CCS within HIV care (group 3) between 2013 and 2019 were included. Data was collected from The Danish HIV Cohort Study and The Danish Pathology Data Bank. Adherence to the CCS program was defined as fulfilled if WWH were screened annually.
Results: A total of 804 WWH were included. WWH who accepted CCS within HIV care (group 1; n  = 218) had significantly higher adherence to screening in all study years 22-99% compared with the WWH who declined CCS (group 2; n  = 232) 10-16% and WWH who were not invited for CCS (group 3; n  = 354) 11-25%. There was no significant difference in the prevalence of HPV-specific genotypes and incidence of cellular abnormalities among the three groups.
Conclusion: Integrating CCS for WWH in routine HIV care resulted in higher adherence to the CCS guidelines. Combined services thereby represent an opportunity to engage WWH in HIV care into preventive services.
(Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
References: Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV . Lancet Glob Health 2021; 9:e161–e169.
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer . Lancet 2007; 370:890–907.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J Clin 2021; 71:209–249.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide . J Pathol 1999; 189:12–19.
Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging, Canada's Michael Smith Genome Sciences Centre, Harvard Medical School, Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, HudsonAlpha Institute for Biotechnology, ILSbio, LLC, Indiana University School of Medicine, Institute of Human Virology, Institute for Systems Biology, International Genomics Consortium, Leidos Biomedical, Massachusetts General Hospital, McDonnell Genome Institute at Washington University, Medical College of Wisconsin, Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, NantOmics, National Cancer Institute, National Hospital, Abuja, Nigeria, National Human Genome Research Institute, National Institute of Environmental Health Sciences, National Institute on Deafness &Other Communication Disorders, Ontario Tumour Bank, London Health Sciences Centre, Ontario Tumour Bank, Ontario Institute for Cancer Research, Ontario Tumour Bank, The Ottawa Hospital, Oregon Health &Science University, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, SRA International, St Joseph's Candler Health System, Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University, Research Institute at Nationwide Children's Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Bergen, University of Texas MD Anderson Cancer Center, University of Abuja Teaching Hospital, University of Alabama at Birmingham, University of California, Irvine, University of California Santa Cruz, University of Kansas Medical Center, University of Lausanne, University of New Mexico Health Sciences Center, University of North Carolina at Chapel Hill, University of Oklahoma Health Sciences Center, University of Pittsburgh, University of São Paulo, Ribeir ão Preto Medical School, University of Southern California, University of Washington, University of Wisconsin School of Medicine &Public Health, Van Andel Research Institute, Washington University in St Louis. Integrated genomic and molecular characterization of cervical cancer . Nature 2017; 543:378–384.
Thorsteinsson K, Storgaard M, Katzenstein TL, Ladelund S, Rønsholt FF, Johansen IS, et al. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE . BMC Cancer 2016; 16:866.
Thorsteinsson K, Ladelund S, Storgaard M, Katzenstein TL, Johansen IS, Pedersen G, et al. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE . BMC Infect Dis 2019; 19:740.
Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer . AIDS 2018; 32:795–808.
Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women . J Infect Dis 2001; 184:682–690.
Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study . PLoS One 2011; 6:e22698.
Authority. SSIDH. Cervical cancer screening Guidelines 2012. Available at: https://www.sst.dk/∼/media/B1211EAFEDFB47C5822E883205F99B79.ashx . [Accessed 22 May 2024].
Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America . MMWR Recomm Rep 2009; 58:1–207.
Danish Quality Rapport for HPV Screening 2019. Available at: https://www.sundhed.dk/content/cms/82/4682_dkls_aarsrapport_2019_off_version.pdf . [Accessed 22 May 2024].
Thorsteinsson K, Ladelund S, Jensen-Fangel S, Katzenstein TL, Johansen IS, Pedersen G, et al. Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general population . BMC Infect Dis 2014; 14:256.
Dugué P-A, Lynge E, Bjerregaard B, Rebolj M. Nonparticipation in screening: the case of cervical cancer in Denmark . Prev Med 2012; 54:266–269.
Institut SS. HIV in Denmark. Available at: https://www.ssi.dk/sygdomme-beredskab-og-forskning/sygdomsleksikon/h/aids---hiv . [Accessed 22 May 2024].
Statens Serum Institut. Hiv - opgørelse over sygdomsforekomst 2020. Available at: https://www.ssi.dk/sygdomme-beredskab-og-forskning/sygdomsovervaagning/h/hiv-2020 . [Accessed 22 May 2024].
Bonde J, Rebolj M, Ejegod DM, Preisler S, Lynge E, Rygaard C. HPV prevalence and genotype distribution in a population-based split-sample study of well screened women using CLART HPV2 human papillomavirus genotype microarray system . BMC Infect Dis 2014; 14:413.
Pedersen CB. The Danish Civil Registration System . Scand J Public Health 2011; 39: (7 Suppl): 22–25.
Omland LH, Ahlström MG, Obel N. Cohort profile update: the Danish HIV Cohort Study (DHCS) . Int J Epidemiol 2014; 43:1769e–1769e.
Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank . Clin Epidemiol 2010; 2:51–56.
Sun J, Frick KD, Liang H, Chow CM, Aronowitz S, Shi L. Examining cancer screening disparities by race/ethnicity and insurance groups: a comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States . PLoS One 2024; 19:e0290105.
McDaniel CC, Hallam HH, Cadwallader T, Lee HY, Chou C. Persistent racial disparities in cervical cancer screening with Pap test . Prev Med Rep 2021; 24:101652.
Hall IJ, Tangka FKL, Sabatino SA, Thompson TD, Graubard BI, Breen N. Patterns and trends in cancer screening in the United States . Prev Chronic Dis 2018; 15:E97.
Hirth JM, Laz TH, Rahman M, Berenson AB. Racial/ethnic differences affecting adherence to cancer screening guidelines among women . J Womens Health (Larchmt) 2016; 25:371–380.
de Pokomandy A, Burchell AN, Salters K, Ding E, O’Brien N, Bakombo DM, et al. CHIWOS Research Team. Cervical cancer screening among women living with HIV: a cross-sectional study using the baseline questionnaire data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) . CMAJ Open 2019; 7:E217–E226.
Oster AM, Sullivan PS, Blair JM. Prevalence of cervical cancer screening of HIV-infected women in the United States . J Acquir Immune Defic Syndr 2009; 51:430–436.
Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis . Cancer Causes Control 2009; 20:1–13.
Stein MD, Cunningham WE, Nakazono T, Turner BJ, Andersen RM, Bozzette SA, et al. HCSUS Consortium. Screening for cervical cancer in HIV-infected women receiving care in the United States . J Acquir Immune Defic Syndr 2001; 27:463–466.
Ciceron AC, Jeon MJ, Monroe AK, Clausen ME, Magnus M, Le D. HPV knowledge, screening barriers and facilitators, and sources of health information among women living with HIV: perspectives from the DC community during the COVID-19 pandemic . BMC Womens Health 2022; 22:110.
Le D, Coriolan Ciceron A, Jeon MJ, Gonzalez LI, Jordan JA, Bordon J, et al. Cervical cancer prevention and high-risk HPV self-sampling awareness and acceptability among women living with HIV: a qualitative investigation from the patients’ and providers’ perspectives . Curr Oncol 2022; 29:516–533.
Worthington C, McLeish K, Fuller-Thomson E. Adherence over time to cervical cancer screening guidelines: insights from the Canadian National Population Health Survey . J Womens Health (Larchmt) 2012; 21:199–208.
Musa J, Achenbach CJ, O’Dwyer LC, Evans CT, McHugh M, Hou L, et al. Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis . PLoS One 2017; 12:e0183924.
Stockton MA, Giger K, Nyblade L. A scoping review of the role of HIV-related stigma and discrimination in noncommunicable disease care . PLoS One 2018; 13:e0199602.
Smith ML, Chan DJ. Cervical screening rates among culturally diverse women in a specialist HIV/AIDS clinic . Int J STD AIDS 2011; 22:614–615.
Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, et al. Integrating cervical cancer with HIV healthcare services: a systematic review . PLoS One 2017; 12:e0181156.
Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus . CA A Cancer J Clin 2021; 71:505–526.
Ebisch RMF, Ketelaars PJW, van der Sanden WMH, Schmeink CE, Lenselink CH, Siebers AG, et al. Screening for persistent high-risk HPV infections may be a valuable screening method for young women: a retrospective cohort study . PLoS One 2018; 13:e0206219.
تواريخ الأحداث: Date Created: 20240701 Date Completed: 20240801 Latest Revision: 20240801
رمز التحديث: 20240802
DOI: 10.1097/QAD.0000000000003972
PMID: 38950190
قاعدة البيانات: MEDLINE
الوصف
تدمد:1473-5571
DOI:10.1097/QAD.0000000000003972